Schedule 13G ownership disclosure

Viridian Therapeutics Inc

Security class unavailable · CUSIP: 92790C104

Event date: 2021-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-257239
Form type
SC 13G
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Aug 26, 2021
Reporting period
Aug 16, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub